*Please do not use these forms for marketing solicitations. Agency, (888) 934-3354. Commercial Services, (888) 934-3354. Escrow/Settlement, (888) 934-3354.
CTI BioPharma focuses on the acquisition, development and commercialization of therapies for blood-related cancers that offer unique benefits to patients.
Our management and investor relations team provide updates throughout the year through conference calls, investor events, press releases and SEC filings. We ...
Apr 12, 2023 · CTI is conducting the Phase 3 PACIFICA study of VONJO in patients with myelofibrosis and severe thrombocytopenia as a post-marketing requirement ...
The number of outstanding shares of the registrant's common stock as of February 21, 2023 was 131,835,892 . DOCUMENTS INCORPORATED BY REFERENCE. Portions ...
Crinetics Pharmaceuticals (CRNX) Investor Relations – Press releases, events, financials / SEC filings, corporate governance, FAQ, stock quote chart, ...
Ticker CTIC. Exchange NASDAQ More. Industry Biotechnology More; Sector Healthcare More. CTI BioPharma Corp Logo Image. 201-500 Employees; Based in Seattle ...
Missing: investor relations
People also ask
What is the annual revenue of CTI BioPharma Corporation?
What is the phone number for CTI BioPharma?
Investor Relations. IR Overview · Corporate Governance · Stock information · Financial Reports · Key Financials · Announcements & Circulars · Investor Briefings.
May 30, 2023 · Copies of the documents filed with the SEC by CTI will be available free of charge under the "Investor Relations" section of CTI's internet ...
Access CTI BioPharma Corp (CTIC) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using Quartr.